Weiping Zou
Charles B de Nancrede Research Professor of Surgery
Professor of Surgery
Professor of Pathology
[email protected]

Available to mentor

Weiping Zou
Professor
  • Center Memberships
  • Recent Publications
  • Center Memberships
    • Center Member
      Rogel Cancer Center
    • Center Member
      MM-PKUHSC Joint Institute
    Recent Publications See All Publications
    • Journal Article
      Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043.
      Zakharia Y, Singer EA, Acharyya S, Garje R, Joshi M, Peace D, Baladandayuthapani V, Majumdar A, Li X, Lalancette C, Kryczek I, Zou W, Alva A. Nat Commun, 2024 Feb 1; 15 (1): 972 DOI:10.1038/s41467-024-45216-z
      PMID: 38302476
    • Journal Article
      PIKfyve, expressed by CD11c-positive cells, controls tumor immunity.
      Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC-Y, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. Nat Commun, 2024 Jun 28; 15 (1): 5487 DOI:10.1038/s41467-024-48931-9
      PMID: 38942798
    • Journal Article
      Artificial intelligence to unlock real-world evidence in clinical oncology: A primer on recent advances.
      Bryant AK, Zamora-Resendiz R, Dai X, Morrow D, Lin Y, Jungles KM, Rae JM, Tate A, Pearson AN, Jiang R, Fritsche L, Lawrence TS, Zou W, Schipper M, Ramnath N, Yoo S, Crivelli S, Green MD. Cancer Med, 2024 Jun; 13 (12): e7253 DOI:10.1002/cam4.7253
      PMID: 38899720
    • Journal Article
      Beyond the Barrier: Unraveling the Mechanisms of Immunotherapy Resistance.
      Bell HN, Zou W. Annu Rev Immunol, 2024 Jun; 42 (1): 521 - 550. DOI:10.1146/annurev-immunol-101819-024752
      PMID: 38382538
    • Journal Article
      Ironing out the role of ferroptosis in immunity.
      Bell HN, Stockwell BR, Zou W. Immunity, 2024 May 14; 57 (5): 941 - 956. DOI:10.1016/j.immuni.2024.03.019
      PMID: 38749397
    • Journal Article
      PAD4 controls tumor immunity via restraining the MHC class II machinery in macrophages.
      Pitter MR, Kryczek I, Zhang H, Nagarsheth N, Xia H, Wu Z, Tian Y, Okla K, Liao P, Wang W, Zhou J, Li G, Lin H, Vatan L, Grove S, Wei S, Li Y, Zou W. Cell Rep, 2024 Mar 26; 43 (3): 113942 DOI:10.1016/j.celrep.2024.113942
      PMID: 38489266
    • Proceeding / Abstract / Poster
      Abstract 7479: Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy
      Borker P, Bao Y, Qiao Y, Chinnaiyan A, Choi JE, Zhang Y, Mannan R, Cheng C, He T, Zheng Y, Yu J, Gondal M, Cruz G, Grove SS, Cao X, Su F, Wang R, Chang Y, Kryczek I, Cieslik M, Green MD, Zou W. Cancer Research, 2024 Mar 22; 84 (6_Supplement): 7479 - 7479. DOI:10.1158/1538-7445.am2024-7479
    • Preprint
      PIKfyve controls dendritic cell function and tumor immunity
      Choi JE, Qiao Y, Kryczek I, Yu J, Gurkan J, Bao Y, Gondal M, Tien JC-Y, Maj T, Yazdani S, Parolia A, Xia H, Zhou J, Wei S, Grove S, Vatan L, Lin H, Li G, Zheng Y, Zhang Y, Cao X, Su F, Wang R, He T, Cieslik M, Green MD, Zou W, Chinnaiyan AM. bioRxiv, DOI:10.1101/2024.02.28.582543
    Featured News & Stories Cancer cell microscopic, colored yellow
    Health Lab
    Researchers find common immune system mechanism between pregnancy, cancer
    Researchers find common immune system mechanism between pregnancy, cancer